Discernment of rare alleles in circulating free DNA (cfDNA) may be a useful method for detecting the presence of new or recurring cancer long before it becomes symptomatic and, perhaps, when it is more treatable. Unfortunately the false-positive rate of current methods reduce specificity to an unacceptable level at allele frequencies of less than ~0.5%.
Tissue and cfDNA Rare Alleles How Low Can We Go
Video Apr 28, 2015
Signals Notebook: The Modern Electronic Lab Notebook from PerkinElmerVideo
PerkinElmer Signals Notebook allows you to achieve meaningful scientific breakthroughs – faster, smarter and easier to keep track of your material evidence.WATCH NOW